Helix BioPharma Corp. (HBPCF)
OTCMKTS · Delayed Price · Currency is USD
0.6000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Helix BioPharma Employees
Helix BioPharma had 7 employees as of July 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-$985,553
Market Cap
58.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 7 | -2 | -22.22% |
| Jul 31, 2023 | 9 | 2 | 28.57% |
| Jul 31, 2022 | 7 | -3 | -30.00% |
| Jul 31, 2021 | 10 | -1 | -4.76% |
| Jul 31, 2020 | 11 | -8 | -41.67% |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Helix BioPharma News
- 6 weeks ago - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025 - TheNewswire
- 2 months ago - Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones - TheNewswire
- 2 months ago - Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group - TheNewswire
- 2 months ago - Helix BioPharma Corp. (HBP.TO) Signs Capital Raising Agreement with Kerentech Consulting Ltd. - TheNewswire
- 3 months ago - Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers - TheNewswire
- 4 months ago - Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan - TheNewswire
- 4 months ago - Urgent Solutions to Fight Cancer: How Helix BioPharma is Tackling the Toughest Challenges - IBTimes
- 4 months ago - Helix BioPharma Corp. Announces Engagement of Independent Trading Group to Provide Market-Making Services - TheNewswire